Trial Profile
Investigation of factors which are related to urinary volume change after canagliflozin administration
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Dec 2016
Price :
$35
*
At a glance
- Drugs Canagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 15 Dec 2016 Results published in the Advances in Therapy
- 19 May 2016 Status changed from active, no longer recruiting to completed.
- 14 Dec 2015 Status changed from not yet recruiting to recruiting, as reported by University Hospital Medical Information Network - Japan.